Cellectis (CLLS) Non-cash Items (2015 - 2026)
Cellectis (CLLS) posted quarterly Non-cash Items of -$26.5 million for Q1 2026, down 2955.99% year-over-year from $927000.0 in Q1 2025, and up 70.98% quarter-over-quarter from -$91.2 million in Q3 2025.
Cellectis (CLLS) Non-cash Items (2015 - 2026) Analysis & Trends
Cellectis' Non-cash Items history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.
- In Q1 2026, Non-cash Items fell 2955.99% year-over-year to -$26.5 million; the TTM figure through Mar 2026 stood at -$120.1 million (down 600.21% YoY), while the FY2016 annual figure was -$85.4 billion, down 139.41% from the prior year.
- Non-cash Items for Q1 2026 stood at -$26.5 million, up from -$91.2 million in the prior quarter.
- The five-year high for Non-cash Items was $29.5 million in Q2 2022, with the low at -$91.2 million in Q3 2025.
- The 5-year median for Non-cash Items is -$149000.0 (2023), against an average of -$8.9 million.
- Peak annual rise in Non-cash Items reached 75628.21% in 2022, while the deepest fall reached 73065.85% in 2022.
- Cellectis' Non-cash Items stood at $29.5 million in 2022, then plunged by 100.51% to -$149000.0 in 2023, then soared by 15587.92% to $23.1 million in 2024, then sank by 495.31% to -$91.2 million in 2025, then jumped by 70.98% to -$26.5 million in 2026.
- Business Quant data shows CLLS's Non-cash Items at -$26.5 million in Q1 2026, -$91.2 million in Q3 2025, and -$3.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.48 Mn |
| Mar 31, 2026 | -26.48 Mn |
| Sep 30, 2025 | -91.23 Mn |
| Sep 30, 2025 | -91.23 Mn |
| Jun 30, 2025 | -3.30 Mn |
| Jun 30, 2025 | -3.30 Mn |
| Mar 31, 2025 | 927,000.00 |
| Mar 31, 2025 | 927,000.00 |
| Sep 30, 2024 | 23.08 Mn |
| Sep 30, 2024 | 23.08 Mn |
| Jun 30, 2024 | 13.47 Mn |
| Jun 30, 2024 | 13.47 Mn |
| Mar 31, 2024 | -13.47 Mn |
| Mar 31, 2024 | -13.47 Mn |
| Jun 30, 2023 | -149,000.00 |
| Jun 30, 2023 | -149,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Jun 30, 2022 | 29.46 Mn |
| Jun 30, 2022 | 29.46 Mn |